An experimental series in the rabbit was performed to test gadolinium-DTPA (Gd-DTPA) enhancement of VX-2 carcinoma and hemorrhages induced in the soft tissues. The recognition of both malignant and benign lesions was greatly facilitated on T1 weighted images after intravenous administration of 0.3 mmol Gd-DTPA/kg body weight because of reduced T1 relaxation times. Gd-DTPA enhancement reached its maximum after 10–15 minutes and was most apparent in tumor tissue, connective tissue surrounding the tumor and in the area of fresh hemorrhage.
AkinsE. N.FitzsimmonsJ. R.MancusoA. A.AngusL. B.BoucherM.: Improved signal reception using a double loop receiver coil for MR imaging at 0.15 Tesla. (To be published.)
2.
BergquistT. H.: Magnetic resonance imaging. Preliminary experience in orthopedic radiology. Magn. Reson. Imag.2 (1984), 41.
3.
BraschR. C.WeimannH. J.WesbeyG. E.: Contrast-enhanced NMR imaging. Animal studies using Gadolinium-DTPA complex. Amer. J. Roentgenol.142 (1984), 625.
4.
BydderG. M.KingsleyD. P. E.BrownJ.NiendorfH. P.YoungI. R.: MR imaging of meningiomas including studies with and without Gadolinium-DTPA. J. Comput. Assist. Tomogr.9 (1985), 690.
5.
CarrD. H.BrownJ.BydderG. M. et coll.: Gadolinium-DTPA as a contrast agent in MRI. Initial clinical experience in 20 patients. Amer. J. Roentgenol.143 (1984), 215.
6.
ClaussenC.LaniadoM.KaznerE.SchörnerW.FelixR.: Application of contrast agents in CT and MRI (NMR): Their potential in imaging of brain tumors. Neuroradiology27 (1985), 164.
7.
ClaussenC.LaniadoM.SchörnerW. et coll.: Gadolinium-DTPA in MR imaging of glioblastomas and intracranial metastases. Amer. J. Neuroradiol.6 (1985), 669.
8.
FelixR.SchörnerW.LaniadoM. et coll.: Brain tumors. MR imaging with Gadolinium-DTPA. Radiology156 (1985), 681.
9.
FitzsimmonsJ. R.ThomasR. G.MancusoA. A.: Proton imaging with surface coils on a 0.15-T resistive system. Magn. Reson. Med.2 (1985), 180.
10.
GrossmanR. I.WolfG.BieryD. et coll.: Gadolinium enhanced nuclear magnetic resonance images of experimental brain abscess. J. Comput. Assist. Tomogr.8 (1984), 204.
11.
MoonK. L.JrDavisP. L.KaufmannL. et coll.: Nuclear magnetic resonance imaging of a fibrosarcoma tumor implanted in the rat. Radiology148 (1983), 177.
12.
PetterssonH.HamlinD. J.MancusoA.ScottK. N.: Magnetic resonance imaging of the musculoskeletal system. Acta Radiol. Diagnosis26 (1985), 225.
13.
PetterssonH.HamlinD. J.MancusoA.ScottK. N.HamlinD. J.ScottK. N.: MRI of musculoskeletal tumors. Review article, CRC Critical Press Inc, 1986. In press.
14.
HamlinD. J.ScottK. N.KropD.HamlinD.FitzsimmonsJ.: Magnetic resonance imaging of the extremities. II. T1 and T2 relaxation times of muscle and fat. Normal values, reproducibility and dependence on physiologic variations. Acta Radiol. Diagnosis26 (1985), 413.
15.
ReiserM.RuppN.HellerH. J. et coll.: MR-tomography in the diagnosis of malignant soft-tissue tumours. Europ. J. Radiol.4 (1984), 288.
16.
RevelD.BraschR. C.PaajanenH. et coll.: Gd-DTPA contrast enhancement and tissue differentiation in MR imaging of experimental breast carcinoma. Radiology158 (1986), 319.
17.
RichardsonM. L.AmparoE. G.GillespyT.IIIHelmsC. A.DemasB. E.GenantH. K.: Theoretical considerations for optimizing intensity differences between primary musculoskeletal tumors and normal tissue with spin-echo magnetic resonance imaging. Invest. Radiol.20 (1985), 492.
18.
WeimannH. J.BraschR. C.PressW. R.WesbeyG. E.: Characteristics of Gadolinium-DTPA complex. A potential NMR contrast agent. Amer. J. Roentgenol.142 (1984), 619.
19.
ZimmerW. D.BergquistT. H.McLeodR. A. et coll.: Bone tumors. Magnetic resonance imaging versus computed tomography. Radiology155 (1985), 709.
